Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Surrozen (SRZN) EBIT (2021 - 2025)

Surrozen has reported EBIT over the past 5 years, most recently at -$12.6 million for Q4 2025.

  • Quarterly results put EBIT at -$12.6 million for Q4 2025, down 47.1% from a year ago — trailing twelve months through Dec 2025 was -$42.1 million (down 64.81% YoY), and the annual figure for FY2025 was -$42.1 million, down 64.81%.
  • EBIT for Q4 2025 was -$12.6 million at Surrozen, down from -$10.9 million in the prior quarter.
  • Over the last five years, EBIT for SRZN hit a ceiling of $1.2 million in Q3 2024 and a floor of -$15.0 million in Q4 2021.
  • Median EBIT over the past 5 years was -$11.0 million (2023), compared with a mean of -$10.6 million.
  • Biggest five-year swings in EBIT: soared 111.01% in 2024 and later plummeted 983.52% in 2025.
  • Surrozen's EBIT stood at -$15.0 million in 2021, then surged by 85.54% to -$2.2 million in 2022, then tumbled by 348.32% to -$9.7 million in 2023, then increased by 11.64% to -$8.6 million in 2024, then tumbled by 47.1% to -$12.6 million in 2025.
  • The last three reported values for EBIT were -$12.6 million (Q4 2025), -$10.9 million (Q3 2025), and -$9.0 million (Q2 2025) per Business Quant data.